Clinical Trial

A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

Name: A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis — clinical trial record (NCT07184645)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To investigate the superiority of 0.3% OPA-15406 foam to the vehicle in children with atopic dermatitis (AD)

Trial Details

NCT Number	NCT07184645
Lead Sponsor	Otsuka Pharmaceutical Co., Ltd.
Conditions	Atopic Dermatitis (AD)
Enrollment	198 participants
Start Date	2025-09
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2025-09-22